EyeYon Medical
Latest round
- Series C
Last raised
- Mar 2021
Total raised
- $35M
Investors
- 12
About EyeYon Medical
EyeYon Medical Ltd.Founded in 2011 in Israel, EyeYon Medical Ltd. specializes in ophthalmic products that address corneal health issues. The company was established by Nahum Ferera, who also serves as the CEO.EyeYon Medical specializes in innovative ophthalmic solutions aimed at treating corneal conditions, with a focus on preserving and restoring vision for patients worldwide. The company's flagship products include EndoArt®, the first synthetic implant designed to treat corneal edema, and Hyper-CL™, a therapeutic contact lens that enhances the bioavailability of topical medications for various corneal disorders. EndoArt® functions as an artificial layer that minimizes fluid transfer from the aqueous humor to the corneal stroma, effectively addressing endothelial failure and reducing reliance on human donor tissue. Hyper-CL™ serves as a novel drug repository lens, which prolongs the availability of antimicrobial agents directly over the affected cornea, facilitating faster healing in conditions such as bacterial keratitis.EyeYon Medical's revenue model primarily revolves around B2B transactions with healthcare providers and medical institutions that require advanced ophthalmic treatments. The company engages in direct sales of its proprietary products, namely EndoArt® and Hyper-CL™, to surgical centers and eye care professionals. Each product is sold as a one-time purchase, with the potential for repeat orders based on patient needs and treatment outcomes. The firm collaborates with hospitals and medical practitioners, establishing partnerships that enhance distribution across geographical markets, including significant regions in Europe, Asia, and the Americas.In March 2021, EyeYon Medical Ltd. The company is focused on launching new products aimed at treating corneal conditions and plans to target new geographic markets to further its reach. Specific markets for expansion include regions in Europe and Asia, with the intent to enhance accessibility to its innovative ophthalmic solutions.
Who invested in EyeYon Medical
12 investors across 3 rounds
See all investors in EyeYon Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EyeYon Medical
Who invested in EyeYon Medical?
EyeYon Medical has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EyeYon Medical raised?
EyeYon Medical has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did EyeYon Medical last raise money?
EyeYon Medical's most recent round on record is a Series C, in Mar 2021.
What does EyeYon Medical do?
EyeYon Medical is a medical devices & equipment company.
Where is EyeYon Medical headquartered?
EyeYon Medical is headquartered in Israel.
Which VCs invest in companies like EyeYon Medical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at EyeYon Medical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like EyeYon Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.